Category Archives: Cardiology

Written by Mineola American Staff Saturday, 06 September 2014 00:00 Winthrop-University Hospitals division of cardiology annouced that Mineola reisdent Vijayapraveena Paruchuri as director of the center for adult congenital heart disease. Dr. Paruchuri resides in Mineola. Dr. Paruchuri is a welcome addition to the Winthrop team, said Kevin Marzo, MD, chief of the division of cardiology at Winthrop. Due to medical breakthroughs and progress in treatment, children born with congenital heart defects are living longer and reaching adulthood. Dr. Paruchuris care can make all the difference to these adults. Paruchuris postgraduate training includes a residency in internal medicine and a general cardiovascular disease fellowship at Winthrop. She went on to complete an advanced fellowship in adult congenital heart disease at Texas Childrens Hospital, Texas Heart Institute and Baylor College of Medicinea hub for congenital heart surgery. Paruchuri has authored and co-authored articles and abstracts related to her specialty interests in leading medical journals. She has also been the recipient of the John C. Sable Memorial Heart Fund award for her research investigating cardiac disease complicating pregnancy. Paruchuri is a board certified internist and cardiologist who specializes in adult congenital heart disease. She is trained to manage simple to advanced congenital … Continue reading →

September 3, 2014 American College of Cardiology Abdominal fat more strongly associated with high blood pressure risk than overall obesity People with fat around their abdominal area are at greater risk of developing hypertension when compared to those with similar body mass index but fat concentrations elsewhere on the body, according to a study published today in the Journal of the American College of Cardiology. Obesity is a known risk factor for hypertension, or high blood pressure, and it is widely reported that the location of fat on a persons body can lead to increased risk of other health issues like heart disease and cancer. However, the relationship between hypertension and overall obesity versus site-specific fat accumulation is unclear. For this study, 903 patients enrolled in the Dallas Heart Study were followed for an average of seven years to track development of hypertension. Hypertension was classified as a systolic blood pressure of greater or equal to 140, diastolic blood pressure of greater or equal to 90, or initiation of blood pressure medications. Patients also received imaging of visceral fat, or fat located deep in the abdominal cavity between the organs; subcutaneous fat, or visible fat located all over the body; … Continue reading →

ESC TV 2014 - e-Health: A vital part of modern cardiology Interviewee : Prof. Martin Cowie, FESC, London, United Kingdom Interviewer : Dr. Enno van der Velde, FESC, Leiden, Netherlands ESC Congress 2014 : Smartphone... By: European Society of Cardiology … Continue reading →

PUBLIC RELEASE DATE: 2-Sep-2014 Contact: ESC Press Office press@escardio.org 34-670-521-210 European Society of Cardiology Barcelona, Spain Tuesday 2 September 2014: Digoxin may increase the risk of death in patients with atrial fibrillation (AF) by approximately 20%, according to results from the ROCKET AF trial presented at ESC Congress today by Dr Manesh Patel, director of interventional cardiology and catheterisation labs at Duke University Health System in Durham, North Carolina, US. The findings suggest that caution may be needed when using digoxin in complex AF patients but further studies are needed to confirm the observations. Dr Patel said: "In this subanalysis of the ROCKET AF trial we found that AF patients who took the drug digoxin had an increased risk of adverse cardiovascular events, including vascular death or sudden death." He added: "Digoxin, which works to strengthen heart contractions, is one of the oldest medications used in the treatment of patients with heart failure and it has also been used in patients who have AF. However the use of digoxin in AF patients has not been rigorously studied in randomised trials. We therefore conducted a retrospective subanalysis of the ROCKET AF trial to determine the effect of digoxin on the risk … Continue reading →

In recent years interventional cardiologists have started to use a new catheter technique, called fractional flow reserve (FFR), in an attempt to assess which blocked vessels might benefit from a stent.Two studies presented at the European Society of Cardiology meeting in Barcelona offered new support for FFR, which has been slowly but surely gaining traction in the interventional cardiology community. Bernard De Bruyne presented 2-year results from the FAME 2 (Fractional flow reserve versus Angiography for Multivessel Evaluation 2) study (simultaneously published in theNew England Journal of Medicine). FAME 2 was designed to find out whether PCI, with the help of FFR, can reduce the rate of hard endpoints in stable coronary artery disease compared to medical therapy. (FAME 2 was sponsored by St. Jude Medical, which makes an FFR pressure wire. Another major player in the field is the Volcano Corporation.) 1220 patients with stable CAD underwent angiography with FFR. 27% of the group had no ischemic lesions on FFR (>.80 pressure gradient) and were entered in a separate registry. 73% had at least one stenosis with a pressure gradient of .80 or under and were randomized to PCI and medical therapy or medical therapy alone. At 2 years … Continue reading →

The ESC today announced that Jeroen Bax, a Dutch cardiologist, will serve as the groups President Elect for the next two years before becoming President starting in 2016. Bax is a professor of cardiology at Leiden University Medical Center. Bax is also known for his very close collaboration with Don Poldermans, the disgraced Dutch researcher who has been accused of significant and multiple examples of scientific misconduct. The Poldermans case has led to the retraction of several important papers and the expectation that many more will ultimately be retracted. The case created an additional sensation when it was found that ESC guidelines on perioperative use of beta blockers relied heavily on trials authored by Poldermans and Bax leading to controversy, recriminations, and a complete revision of the guideline. In addition, Bax and Poldermans were both co-authors of the guideline. Further, Poldermans was the chair of the writing committee and Bax was the chair of the entire ESC Cardiology Practice Guidelines Committee. The case is still far from settled, since a new round of accusations was launched just last week in TheBMJ(additional coverage on TheHeart.Org). The new charges also bring a new focus on flaws and inconsistencies in the seminal 1999New … Continue reading →

PUBLIC RELEASE DATE: 1-Sep-2014 Contact: Rachel Cagan rcagan@acc.org 202-375-6395 American College of Cardiology WASHINGTON (Sept. 1, 2014) People with fat around their abdominal area are at greater risk of developing hypertension when compared to those with similar body mass index but fat concentrations elsewhere on the body, according to a study published today in the Journal of the American College of Cardiology. Obesity is a known risk factor for hypertension, or high blood pressure, and it is widely reported that the location of fat on a person's body can lead to increased risk of other health issues like heart disease and cancer. However, the relationship between hypertension and overall obesity versus site-specific fat accumulation is unclear. For this study, 903 patients enrolled in the Dallas Heart Study were followed for an average of seven years to track development of hypertension. Hypertension was classified as a systolic blood pressure of greater or equal to 140, diastolic blood pressure of greater or equal to 90, or initiation of blood pressure medications. Patients also received imaging of visceral fat, or fat located deep in the abdominal cavity between the organs; subcutaneous fat, or visible fat located all over the body; and lower-body fat. … Continue reading →

Harrington European Society of Cardiology 2014 So Far European Society of Cardiology Day One Feedback. By: Medscape Cardiology The Heart.Org … Continue reading →

ESC Cardiology Congress in Barcelona, 2014 http://www.siemens.com/esc It is amazing what cardiovascular medicine can accomplish today. Siemens presents at ESC Cardiology Congress in Barcelna, 2104, Booth #F300, Exhibition Hall. We look... By: Siemens … Continue reading →

Cardiology for the PCP Part 002 Mangement of outpatient heart failure in 2014, by Diana Rinkevich, MD. The Cardiovascular Division at OHSU presentation at Columbia Memorial Hospital in Asto... By: CPM Personal … Continue reading →